MedWatch http://medwatch.dk/ MedWatch da Copyright 2012, MedWatch Wed, 16 Aug 2017 14:23:51 GMT MedWatch - seneste nyt MedWatch - seneste nyt medwatch.dk 2017-08-16T14:23:51Z da Copyright 2012, MedWatch MedWatch http://medwatch.dk/mwimg/logo/main_logo.png http://medwatch.dk/ Zealand carries out USD 89m IPO in the US http://medwatch.dk/secure/Top_picks_in_english/article9792532.ece?utm_source=Feed&utm_medium=latest Zealand Pharma has listed on the Nasdaq Global Select Market in addition to its listing in Copenhagen, raising USD 89 in the process. But the move does not mean the biotech company has lost faith in the Danish investor base, says CEO Britt Meelby Jensen. Top picks in English Wed, 16 Aug 2017 14:23:51 GMT http://medwatch.dk/secure/Top_picks_in_english/article9792532.ece?utm_source=Feed&utm_medium=latest BY ELIZABETH MØNSTED JOHANSEN 2017-08-16T14:23:51Z true Darzalex is still the “star of the show” for Genmab http://medwatch.dk/secure/Top_picks_in_english/article9778473.ece?utm_source=Feed&utm_medium=latest Genmab’s Darzalex royalties now cover the company’s operating costs and in addition to that, the cancer drug continues its expansion to new markets. And according to CEO, Jan van de Winkel, Genmab could potentially raise its guidance this year. Top picks in English Wed, 16 Aug 2017 12:51:27 GMT http://medwatch.dk/secure/Top_picks_in_english/article9778473.ece?utm_source=Feed&utm_medium=latest BY MARTIN HAVTORN PETERSEN 2017-08-16T12:51:27Z true Novo expands its executive team http://medwatch.dk/secure/Top_picks_in_english/article9791996.ece?utm_source=Feed&utm_medium=latest Novo Nordisk has promoted two of its regional directors to its executive management team, which has undergone a slew of changes in the past year. Top picks in English Wed, 16 Aug 2017 12:31:55 GMT http://medwatch.dk/secure/Top_picks_in_english/article9791996.ece?utm_source=Feed&utm_medium=latest BY ELIZABETH MØNSTED JOHANSEN 2017-08-16T12:31:55Z true ALK CEO: We call the FDA on a daily basis http://medwatch.dk/secure/Top_picks_in_english/article9791890.ece?utm_source=Feed&utm_medium=latest Denmark’s ALK is ready to go “full steam” in the launch of a promising tablet against house dust mite allergy on the US market as early as this year. The only obstacle is a formal handover of the marketing permit from former partner Merck, which could push the launch into 2018. Top picks in English Wed, 16 Aug 2017 10:08:32 GMT http://medwatch.dk/secure/Top_picks_in_english/article9791890.ece?utm_source=Feed&utm_medium=latest BY LONNI PARK LYNGE 2017-08-16T10:08:32Z true Bioporto CEO despite growing deficit: ”A fantastic six months” http://medwatch.dk/secure/Top_picks_in_english/article9778846.ece?utm_source=Feed&utm_medium=latest Bioporto’s sales of antibodies and the kidney test NGAL for research use have grown rapidly in 2017. Despite this, the company is forced to downgrade its financial expectations, now expecting a larger deficit for the year. But there is a perfectly good reason for that, explains the CEO. Top picks in English Wed, 16 Aug 2017 09:02:03 GMT http://medwatch.dk/secure/Top_picks_in_english/article9778846.ece?utm_source=Feed&utm_medium=latest BY MIKKEL AABENHUS HEMMINGSEN 2017-08-16T09:02:03Z true Kåre Schultz after guidance hike: Hard to gauge generic competition http://medwatch.dk/secure/Top_picks_in_english/article9775699.ece?utm_source=Feed&utm_medium=latest The US competitor to Lundbeck’s epilepsy drug Sabril is long in coming and this is partly the reason behind the new guidance hike for the Danish company. In the first half year of 2017, Sabril continued to gain market shares in the US. Top picks in English Wed, 16 Aug 2017 08:48:47 GMT http://medwatch.dk/secure/Top_picks_in_english/article9775699.ece?utm_source=Feed&utm_medium=latest BY MIKKEL AABENHUS HEMMINGSEN 2017-08-16T08:48:47Z true Novo will no longer offer price guidance http://medwatch.dk/secure/Top_picks_in_english/article9774869.ece?utm_source=Feed&utm_medium=latest Novo Nordisk will no longer announce the expected price development for its products on the US market. Top picks in English Wed, 09 Aug 2017 15:53:02 GMT http://medwatch.dk/secure/Top_picks_in_english/article9774869.ece?utm_source=Feed&utm_medium=latest BY RITZAU FINANS 2017-08-09T15:53:02Z true Zealand aims to raise USD 78 million in US IPO http://medwatch.dk/secure/Top_picks_in_english/article9775113.ece?utm_source=Feed&utm_medium=latest The Danish biotech company Zealand Pharma has now priced its initial public offering of shares in the US. Top picks in English Wed, 09 Aug 2017 15:46:23 GMT http://medwatch.dk/secure/Top_picks_in_english/article9775113.ece?utm_source=Feed&utm_medium=latest BY RITZAU FINANS 2017-08-09T15:46:23Z true Novo Holdings invests in Canadian company http://medwatch.dk/secure/Top_picks_in_english/article9772809.ece?utm_source=Feed&utm_medium=latest Once again, Novo Holdings has led a sizeable investment round in North America. The company gets a position on the board of the new portfolio company, which develops a nasal spray against atrial fibrillation. Top picks in English Wed, 09 Aug 2017 10:36:30 GMT http://medwatch.dk/secure/Top_picks_in_english/article9772809.ece?utm_source=Feed&utm_medium=latest BY MARTIN HAVTORN PETERSEN 2017-08-09T10:36:30Z true AI to help Danish scientists halt premature aging http://medwatch.dk/secure/Top_picks_in_english/article9772523.ece?utm_source=Feed&utm_medium=latest Molecular researchers from the University of Copenhagen have teamed up with the US-based company Insilico Medicine specialized in artificial intelligence. The hope is to develop new drugs against age-related diseases such as Alzheimer’s, Parkinson’s, and cardiovascular diseases. Top picks in English Wed, 09 Aug 2017 09:18:09 GMT http://medwatch.dk/secure/Top_picks_in_english/article9772523.ece?utm_source=Feed&utm_medium=latest BY MIKKEL AABENHUS HEMMINGSEN 2017-08-09T09:18:09Z true Major Lundbeck study to reveal causes of psychiatric disorders http://medwatch.dk/secure/Top_picks_in_english/article9772251.ece?utm_source=Feed&utm_medium=latest Lundbeck is looking for 25,000 people for a major research project. The aim is to get a better knowledge about what factors affect the development of Major Depressive Disorder (MDD) and Bipolar Depression. Top picks in English Tue, 08 Aug 2017 12:19:45 GMT http://medwatch.dk/secure/Top_picks_in_english/article9772251.ece?utm_source=Feed&utm_medium=latest BY MIKKEL AABENHUS HEMMINGSEN 2017-08-08T12:19:45Z true Danish Teva employees will not be affected by mass layoffs http://medwatch.dk/secure/Top_picks_in_english/article9772040.ece?utm_source=Feed&utm_medium=latest Teva has launched a cost-cutting initiative that will see the company withdrawing from 45 countries and getting rid of 7,000 employees. But the Danish unit will not be affected. Top picks in English Tue, 08 Aug 2017 10:29:25 GMT http://medwatch.dk/secure/Top_picks_in_english/article9772040.ece?utm_source=Feed&utm_medium=latest BY MIKKEL AABENHUS HEMMINGSEN 2017-08-08T10:29:25Z true